Scienmag

OCTOBER 14, 2020

Scientists prove cell-cultured meat products can offer enhanced nutrition compared to conventionally produced meat A group of researchers at Tufts University have genetically engineered cow muscle cells to produce plant nutrients not natively found in beef cells.

Engineer 40

Engineer Genetic Engineering Genetics Scientist 40

XTalks

MARCH 18, 2024

By genetically editing microorganisms, scientists can now manipulate the metabolic pathways to produce foods with desirable properties. The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

Drug Discovery World

OCTOBER 26, 2022

An international team of scientists have engineered protein banana lectin, or BanLec, to create a new version that can fight off a range of viruses without unwanted side effects. . But it’s also exciting to have created it by engineering a lectin molecule for the first time, by understanding and then targeting the structure.” .

Engineer 52

Engineer Genetic Engineering Scientist Protein 52

Scienmag

DECEMBER 21, 2020

Credit: Agricultural Research Service-USDA.

Genetic Engineering 52

Genetic Engineering Engineer Genetics Scientist 52

pharmaphorum

DECEMBER 24, 2020

A serotonin sensor designed using Artificial Intelligence (AI) could help scientists study sleep and mental health and potentially find new neurology drugs. After three rounds of testing, the scientists settled on one. The researchers used machine learning algorithms to help a computer ‘think up’ 250,000 new designs.

Development 64

Development Drugs Protein Genetic Engineering 64

pharmaphorum

JULY 27, 2021

AstraZeneca has formed a partnership with Regeneron to investigate the potential of treating obesity using drugs directed at GPR75, a protective gene identified by scientists at the Regeneron Genetics Centre.

Gene 52

Gene Drugs Genetic Engineering Genetics 52

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

The Pharma Data

JANUARY 4, 2021

But scientists at the University of California (UC), Santa Barbara, believe fluoride may offer hope in the fight against antibiotic-resistant bacteria. The UC Santa Barbara research uses a method that addresses not only antibiotic overuse, but also the containment of genetically modified organisms (GMOs). “If ” Source link.

Bacteria 52

Bacteria Engineer Genetics Genetic Engineering 52

XTalks

JULY 31, 2020

The study developed and researched microbe-controlled and genetically-engineered mice to understand the healing response in the intestine when receiving specific signals from bacteria. In this study, scientists found that IP3 can come from bacteria and not just our own cells.

Bacteria 98

Bacteria Genetic Engineering Engineer Research 98

Pharmaceutical Technology

APRIL 5, 2023

BL: [It is] distressing as a scientist to work on something that patients cannot access. First, by going back to the lab and looking at how we can engineer the process to make these therapies much less expensive. Exa-cel is almost certainly going to the first CRISPR engineered product [to be approved].

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

Drug Discovery World

JULY 5, 2023

A fulfilling part of my job is meeting the scientists, companies, and institutions at the forefront of ground-breaking research that are advancing patient health outcomes. MG: I meet regularly with the brilliant European scientists driving cutting edge global cancer research.

Research 98

Research Protein Scientist Immune Response 98

pharmaphorum

MARCH 10, 2021

The study suggests that serum taken from patients injected with the mRNA shot, also known as BNT162b2, was able to neutralise a genetically engineered version of SARS-CoV-2 with the P.1 1 – that is worrying health officials around the world. . 1 mutations, as well as variants from the UK and South Africa.

Vaccination 58

Vaccination Vaccine Genetic Engineering Engineer 58

Drug Discovery World

NOVEMBER 17, 2022

The rapidly growing area of synthetic biology – including molecular biology, biotechnology, biophysics, and genetic engineering – is having a marked impact on the drug discovery landscape. Lu Rahman selects some recent synthetic biology innovations and the potential they hold to benefit drug discovery. .

Bacteria 52

Bacteria Engineer Gene Genetics 52

Drug Discovery World

MAY 25, 2023

Using complex models of cancer for preclinical testing After a coffee break, Prof Sansom was back behind the podium talking about the MRC National Mouse Genetics Network. Advances like genetically engineered mouse models (GEMMs), patient-derived xenografts (PDXs) and organoids are allowing the integration of mouse models with human cohorts.

Research 52

Research Drugs In-Vitro Insulin 52

Drug Discovery World

OCTOBER 26, 2022

A new method to study the proteins released by cells, which could lead to new biomarkers for diseases including cancer, has been developed by scientists at the Francis Crick Institute and Imperial College London. . The researchers genetically modify the cell type they want to study, so that only this type adds the sugar to its proteins.

Protein 52

Protein Genetics Containment Research 52

Drug Discovery World

FEBRUARY 14, 2024

Adding automation Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. However, such achievements can only be achieved by leveraging research strengths, regulatory capabilities and technical platforms.

Protein 59

Protein Vaccination Vaccine Manufacturing 59

The Pharma Data

JUNE 1, 2022

Scientists who have long studied this molecule’s functions in bacterial infections traced development of extensive lung damage in infected mice to heightened levels of the enzyme triggered by the invading SARS-CoV-2 virus. They used a version of the SARS-CoV-2 virus that other scientists have engineered specifically to cause disease in mice.

Immune Response 52

Immune Response Genetic Engineering Engineer Research 52

Cloudbyz

MARCH 5, 2024

Growing Demand for Personalized Medicine: There is a growing demand for personalized medicine, which aims to tailor treatments to individual patients based on their genetic makeup, lifestyle, and environment. In this endeavor, collaboration between scientists, regulatory bodies, healthcare providers, and patients will be key.

Development 75

Development Drugs Manufacturing Immune Response 75

XTalks

SEPTEMBER 15, 2022

Food products which are developed using genetically modified organisms (GMOs) are possible through bioengineering and precision fermentation is powered by biotech. The federal law that mandates some genetically modified (GM) food and beverage items to be labeled calls them “bioengineered.”

FDA Approval 95

FDA Approval Genetic Engineering Genetics Production 95

pharmaphorum

NOVEMBER 1, 2021

Delytact (teserpaturev) is a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1) that was approved for marketing in Japan earlier this year, and received pricing approval in August at 1.43 It was discovered by scientists led by Prof Tomoki Todo of the University of Tokyo.

Genetic Engineering 120

Genetic Engineering Clinical Trials Clinical Trials Trials 120

Drug Discovery World

FEBRUARY 3, 2023

One of these candidates is VSV-SUDV, developed and tested by scientists at NIH’s National Institute of Allergy and Infectious Diseases in Hamilton, Montana. No treatment or vaccine for SUDV disease is licensed, although candidates are in clinical and preclinical trials.

Vaccination 52

Vaccination Vaccine Genetic Engineering Protein 52

Drug Discovery World

JULY 22, 2022

By Courtney Ferrebee, PhD, Field Applications Scientist, Taconic Biosciences. The future could involve creating genetically engineered DCs or “CAR-DC” cells using patient-derived neoantigen-loaded cells to improve clinical outcomes 30. Courtney Ferrebee, PhD, is a field applications scientist at Taconic Biosciences.

In-Vivo 52

In-Vivo Engineer In-Vitro Antibody 52

Drug Discovery World

NOVEMBER 8, 2023

Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’. Mireille Vankemmelbeke, PhD, Principal Scientist, Biodiscovery, Scancell, on: ‘Glycan and novel targets for bispecific cancer therapy’.

Antibody 64

Antibody Engineer Protein Scientist 64

Drug Discovery World

SEPTEMBER 28, 2022

Scientists from Tel Aviv University have deciphered the mechanism that enables skin cancer to metastasise to the brain and were able to delay the spread of the disease by 60-80% using existing treatments. . Once melanoma, or skin cancer, spreads to the brain, it becomes extremely aggressive. Spread of metastases delayed .

Research 52

Research Gene Editing Genetic Engineering Protein 52

Drug Discovery World

NOVEMBER 9, 2023

Gail Calvert, Field Application Scientist, Sartorius UK, on: ‘Leveraging integrated and advanced technologies for successful cell line development’. Engineering for higher avidity and multi-valency Following chairperson’s remarks from Bruce Keyt, PhD, CSO, R&D, IGM Biosciences, there will be three presentations in this session.

Engineer 52

Engineer Antibody Protein In-Vivo 52

pharmaphorum

SEPTEMBER 13, 2022

During this period, Nobel prize-winning German scientist Paul Ehrlich developed his lock-key hypothesis of molecules that specifically bind to cell receptors. Building on the success of cytokine-based immunotherapies, scientists continued to seek other areas where the immune system could be leveraged against tumours.

Genome Project 88

Genome Project Genome Genomics DNA 88

Drug Discovery World

FEBRUARY 15, 2023

Genetically modified T cells stimulated with IL2 are now administered as cell therapy for multiple cancer cell types with beneficial results 3,4. Genetically engineered mouse models (GEMM) recapitulate the stromal biology of different human cancers including the tumour microenvironment that regulates the disease process.

Research 52

Research In-Vitro In-Vivo Development 52

Drug Discovery World

MARCH 13, 2023

New and innovative methods are on the horizon, including residuals analysis using mass spectroscopy, artificial intelligence, and machine learning to find better targeting constructs for genetically modified therapies, and sophisticated cell-based assays for defining cell-cell interactions. Genetic Engineering & Biotechnology News.

Gene Therapy 52

Gene Therapy Gene Manufacturing Development 52

The Pharma Data

JANUARY 24, 2021

Initial funding for this work was received from the Chief Scientist Group, Scottish Government and was co-ordinated through the University of Aberdeen. At Elasmogen we have been able to capture, using the latest protein and genetic engineering techniques, the immune system of 10,000 shark equivalents in a test-tube.

Antibody 52

Antibody Protein Research Genetic Engineering 52

Drug Discovery World

JANUARY 23, 2023

Increasing interest in CRISPR-Cas gene editing systems over recent years has delivered innovative developments in precision genome engineering technologies, holding enormous potential for applications across the healthcare sector. Single-cell RNA-sequencing of differentiating iPS cells reveals dynamic genetic effects on gene expression.

Gene Editing 52

Gene Editing Gene Engineer DNA 52